Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VX-659
VX-659
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
CP Wire
Thu, 09/6/18 - 09:35 am
Vertex Pharmaceuticals
VX-659
VX-445
correctors
cystic fibrosis
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Thu, 09/6/18 - 09:20 am
Vertex Pharmaceuticals
VX-659
VX-445
cystic fibrosis
Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market
Forbes
Thu, 02/1/18 - 09:32 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
VX-659
VX-445